Target Site Pharmacokinetics of Doripenem After a Single Dose of 500mg in Healthy Volunteers - a Pilot Study.
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2011
At a glance
- Drugs Doripenem (Primary)
- Indications Gram-negative infections; Gram-positive infections; Intra-abdominal infections; Nosocomial pneumonia; Paediatric infections; Respiratory tract infections; Urinary tract infections
- Focus Pharmacokinetics
- 31 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2011 New trial record